is semaglutide being removed from the market FDA moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't them as equivalent to approved drugs and signaling stronger enforcement to protect patients unverified FDA crackdown on off-brand Ozempic

- 30

Side effects of intramuscular Biotin Shots are generally mild and uncommon

Reddys Laboratories, Emcure Pharmaceuticals, Glenmark Pharmaceuticals, Lupin, MSN, Sun Pharma, Torrent Pharmaceuticals, USV, Zydus) 3 companies are using a vial-based format (Eris Lifesciences, Glenmark Pharmaceuticals, Natco Pharma announced a pen for April) 1 company has launched the oral tablet (Torrent Pharmaceuticals) Two companies are taking a broader approach: Glenmark Pharmaceuticals: vial and pen Torrent Pharmaceuticals: pen and tablet China is powering Indias semaglutide generic entries Chinese manufacturers are a critical part of the supply chain behind Indian semaglutide launches not only at the API level, but also upstream in intermediates and key starting materials (Figure 4) : 8 companies (61%) show partial or full dependence on China 3 companies (23%) are fully reliant on China for API manufacturing 5 companies (38%) source APIs from two countries but all still include China Only 4 companies (31%) show no direct China exposure at the API manufacturing level Abbott and Emcure via Novo Nordisk in-licensing from Denmark MSN and Zydus with API manufacturing in India However, China dependency remains present even in some of these cases just further upstream

If you experience significant mood changes, consult your doctor